Navigation Links
BioVex Announces Publication of Phase 2 Melanoma Results With OncoVEX (GM-CSF) in the Journal of Clinical Oncology
Date:11/2/2009

e and death," said Dr. Howard Kaufman of the Rush University Medical Center in Chicago, principal investigator of an ongoing Phase 3 OPTiM(TM) study with OncoVEX (GM-CSF) in Stage III and Stage IV melanoma. "The ability to simply administer the vaccine in the office setting represents a significant improvement in quality of life for patients with melanoma."

"We believe that OncoVEX (GM-CSF) is the most advanced clinical development program globally using viruses for cancer therapy, and we are committed to the further evaluation of OncoVEX (GM-CSF) for the treatment of metastatic melanoma and other solid tumors," said Robert Coffin, PhD, Founder & Chief Technology Officer of BioVex.

About the Phase 2 OncoVEX (GM-CSF) Study in Melanoma

The Phase 2 trial enrolled 50 patients with Stage IIIc (10 patients) and Stage IV melanoma (40 patients) who were treated with OncoVEX (GM-CSF) as a stand-alone therapy. The trial was designed to measure overall objective response, which is defined as a complete response, where disease is completely eliminated, or partial response, where there is a more than 30% reduction in disease burden. The vast majority of patients who entered the study had progressive disease after having failed conventional and experimental prior therapies. Fourteen objective systemic responses (28% objective response rate) were ultimately achieved, including on an extension protocol to which four patients were transferred having completed the main study, including 10 complete responses. Responses have been maintained for up to nearly four years so far. Responses were observed in patients with all stages of disease, including the complete resolution of un-injected visceral deposits.

About the OPTiM(TM) Phase 3 Study

BioVex has now begun a multi-national, randomized Phase 3 OPTiM Study to assess the efficacy and safety of treatment with OncoVEX (GM-CSF) as compared to subcut
'/>"/>

SOURCE BioVex Inc
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. BioVex to Report Phase I/II Clinical Trial Results for the Front Line Treatment of Head and Neck Cancer With OncoVEX GM-CSF at the 2009 American Society of Clinical Oncology Meeting
2. BioVex Announces Regulatory Clearance to Commence a Clinical Study With ImmunoVEX HSV2; A Vaccine Candidate for Genital Herpes
3. BioVex Reports Positive Phase II Clinical Trial Results of OncoVEX GM-CSF in Metastatic Melanoma at the 2008 American Society of Clinical Oncology Meeting
4. BioVex to Report Phase II Clinical Trial Results of OncoVEX GM-CSF in Metastatic Melanoma at the 2008 American Society of Clinical Oncology Meeting
5. BioVex Agrees SPA With the FDA for a Pivotal Study With OncoVEX(GM-CSF) in Metastatic Melanoma and Announces Presentation of Phase II Results at ASCO
6. PDL BioPharma Announces Closing of $300,000,000 Securitization Transaction
7. Arcadia Resources Announces Webcast of Its Fiscal 2010 Second Quarter Conference Call
8. ATS Medical Announces First in World Human Robotic Endoscopic Aortic Valve Replacement
9. Nuevolution Announces Receipt of Milestone Payment From Merck & Co., Inc.
10. Stryker Announces Change in Chairman of the Board of Directors
11. Cardica Announces Fiscal 2010 First Quarter Financial Results and Business Progress
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)...  Following a bipartisan vote in the House ... the Medicare DMEPOS Competitive Bidding Improvement Act of ... released a statement praising the Committee,s work and ... "Today,s mark-up of the Competitive Bidding ... Committee is a critical step forward for this ...
(Date:2/27/2015)... Feb. 27, 2015 Isis Pharmaceuticals, Inc. (Nasdaq: ... both its pro forma net operating loss (NOL) guidance ... strong financial position.  Isis, significantly improved financial results were ... million in payments the Company received from its partners.  ... was a nearly 60% improvement over its 2013 NOL ...
(Date:2/27/2015)... MARLBOROUGH, Mass. , Feb. 27, 2015  Boston ... to participate in the Barclays 2015 Annual Healthcare Conference ... . Dan Brennan , executive vice ... , vice president, Investor Relations, will participate in a ... the host analyst at approximately 1:05 p.m. ET. Following ...
Breaking Medicine Technology:Bidding Fix Takes Major Step Forward After Bipartisan Vote of House Ways and Means Committee 2Isis Reports Financial Results and Highlights for 2014 2Isis Reports Financial Results and Highlights for 2014 3Isis Reports Financial Results and Highlights for 2014 4Isis Reports Financial Results and Highlights for 2014 5Isis Reports Financial Results and Highlights for 2014 6Isis Reports Financial Results and Highlights for 2014 7Isis Reports Financial Results and Highlights for 2014 8Isis Reports Financial Results and Highlights for 2014 9Isis Reports Financial Results and Highlights for 2014 10Isis Reports Financial Results and Highlights for 2014 11Isis Reports Financial Results and Highlights for 2014 12Isis Reports Financial Results and Highlights for 2014 13Isis Reports Financial Results and Highlights for 2014 14Isis Reports Financial Results and Highlights for 2014 15Isis Reports Financial Results and Highlights for 2014 16Isis Reports Financial Results and Highlights for 2014 17Boston Scientific to Participate in the Barclays 2015 Annual Healthcare Conference 2
... 19, 2011 Agendia, an innovative ... published report highlighting the development and validation of ... online in Breast Cancer Research and Treatment ... of Agendia,s Symphony™ suite of breast cancer products, ...
... Sept. 19, 2011 Reportlinker.com announces that ... in its catalogue: South ... to 2017 http://www.reportlinker.com/p0617106/South-and-Central-America-Cardiovascular-Devices-Market-Outlook-to-2017.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Cardiovascular_Devices ... Cardiovascular Devices Market Outlook to 2017 ...
Cached Medicine Technology:Breast Cancer Research and Treatment Highlights Development and Validation of BluePrint® 2Breast Cancer Research and Treatment Highlights Development and Validation of BluePrint® 3South and Central America Cardiovascular Devices Market Outlook to 2017 2South and Central America Cardiovascular Devices Market Outlook to 2017 3South and Central America Cardiovascular Devices Market Outlook to 2017 4South and Central America Cardiovascular Devices Market Outlook to 2017 5South and Central America Cardiovascular Devices Market Outlook to 2017 6South and Central America Cardiovascular Devices Market Outlook to 2017 7South and Central America Cardiovascular Devices Market Outlook to 2017 8South and Central America Cardiovascular Devices Market Outlook to 2017 9South and Central America Cardiovascular Devices Market Outlook to 2017 10South and Central America Cardiovascular Devices Market Outlook to 2017 11South and Central America Cardiovascular Devices Market Outlook to 2017 12South and Central America Cardiovascular Devices Market Outlook to 2017 13South and Central America Cardiovascular Devices Market Outlook to 2017 14South and Central America Cardiovascular Devices Market Outlook to 2017 15South and Central America Cardiovascular Devices Market Outlook to 2017 16South and Central America Cardiovascular Devices Market Outlook to 2017 17
(Date:2/27/2015)... 27, 2015 Undocumented farmworkers are ... to use Medicaid, the federal health insurance program ... a new study from UC Davis Health System. ... of farmworker use of Medicaid, which provides coverage ... documentation status, was having children. , “Undocumented ...
(Date:2/27/2015)... Freeport, ME (PRWEB) February 27, 2015 Royal ... Freeport, ME, reports a new study that found adults who ... to develop type 2 diabetes compared to those who got ... elevated blood sugar levels. , The report is part of ... Being® ,” which Royal River Natural Foods publishes free each ...
(Date:2/27/2015)... 27, 2015 On February 24 2015, Harper’s ... Botox ,” that details the development of RT001, a ... its way through FDA trials. For those afraid of needles, ... very attractive. Of course, if the drug ultimately gets FDA ... physician’s office. (see: goo.gl/PQvQwk) , “As the article notes, the ...
(Date:2/27/2015)... Winter is here, and with it comes ... to snow and ice can be harmful on a dog’s ... The Puppy Store is ready to help pet owners know ... in the winter time. , Ice melts can lead to ... symptoms. Ingestion of ice melt products may cause depression, loss ...
(Date:2/27/2015)... (PRWEB) February 27, 2015 Victorian Hotel ... deals for couples who wanted to spend the auspicious ... opportunity to get a jump on Valentine’s Day with ... stay in one of their luxurious rooms. , ... 13, inviting guests for a mouthwatering 3 course meal ...
Breaking Medicine News(10 mins):Health News:UC Davis Study Finds Undocumented Farmworkers Use Medicaid Half as Often as Documented Farmworkers 2Health News:UC Davis Study Finds Undocumented Farmworkers Use Medicaid Half as Often as Documented Farmworkers 3Health News:New Study Finds Magnesium May Slow Progress of Diabetes, Retailer Reports 2Health News:Is Topical Botox the Next Big Thing? 2Health News:The Puppy Store Helps Dogs Prepare for Harsh Winter Conditions 2Health News:Victorian Hotel Celebrated Valentine’s Day in 2015 With Unique Overnight Deal 2
... value to patients and health-care system overall, , SUNDAY, ... at all these days without stumbling across drug advertisements ... quickly mumbled list of side effects. , If you ... before, you,re right. , The amount of money spent ...
... ... kits for life science and clinical laboratories. , ... Pleasanton, CA (PRWEB) October 4, 2009 -- Arcxis Biotechnologies ... line of nucleic acid isolation and purification kits. These sample preparation kits are optimized ...
... ... group, have won a prestigious ,Top Ten Website, award from the online intelligence experts Hitwise. ... 160+ categories. From January to June 2009 Spire Healthcare was ranked the ninth most visited ... ...
... not waiting for sunrise," says aid worker in Northern Luzon ... the next few hours , ISABELA PROVINCE, Philippines, Oct. 3 ... Isabela Province, one of the areas wracked by Typhoon Parma. ... World Vision programme manager in Northern Luzon. "We will ...
... say, , SATURDAY, Oct. 3 (HealthDay News) -- Imagine that ... of it so you take a picture of it using ... for an opinion. , Or perhaps you have heart disease ... uploads the data to your cardiologist,s computer for review. , ...
... ... the U.S., yet many breast cancer patients are not being informed about all of ... Cancer Awareness Month, Park Meadows Cosmetic Surgery invites women to become more aware about ... ...
Cached Medicine News:Health News:As TV Drug Ads Increase, So Do Concerns 2Health News:As TV Drug Ads Increase, So Do Concerns 3Health News:Arcxis Biotechnologies Announces Release of First Commercial Product for Molecular Analysis 2Health News:Spire Healthcare Win Hitwise Award 2Health News:Typhoon Parma: World Vision Launches Relief Efforts in the Philippines, Pre-positions Supplies in Taiwan 2Health News:In Health Care Today, It's Electronic All the Way 2Health News:In Health Care Today, It's Electronic All the Way 3Health News:Park Meadows Cosmetic Surgery, a Leader in Breast Reconstruction Surgery, Recognizes National Breast Cancer Awareness Month 2Health News:Park Meadows Cosmetic Surgery, a Leader in Breast Reconstruction Surgery, Recognizes National Breast Cancer Awareness Month 3
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: